Observations from GCP Sponsor Inspections
Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has...
Kevin Anderson, Director, Global Clinical Operations, Alexion Pharmaceuticals, offers a perspective on what he has...
Christopher J. Pace, PhD, Director of Infectious Diseases, GlobalData, assesses the impact of the GAIN...
Maura Musciacco, MSc, Neurology & Ophthalmology Director, GlobalData, assesses what the future holds for Pfizer’s...
CTA highlights the best articles from the month of November 2018
Rose Joachim, PhD, Immunology Analyst, GlobalData, examines the impact of newly approved biosimilars on AbbVie’s...
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the...
Jacqueline Mardell, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws...
CTA’s Adeola Coker delves into the key issues facing preclinical trials ahead of Arena International’s...
Michael Sparozic, Lead Trial Supply Operations Manager, Sanofi, address the merits of direct-to-patient shipping to...
Robert Greene, Founder and President, HungerNdThirst Foundation, looks at patient-centric trials of the future